LOX and cancer: Here to evaluate the ability of these molecules to also inhibit growth of Ras- and Raf-mutant cells, we screened these molecules for anti-proliferative activity against three human cancer cell lines with mutations in Ras or Raf: A549 (KRASG12S); LOX IMVI (BRAFV600E); and MelJuso (HRASG13D and NRASQ61L).